Potential Inhibitors from Kolkwitzia amabilis
Author Information
Author(s): Wan Jiang, Zhao Ze-Yu, Wang Can, Jiang Chun-Xiao, Tong Ying-Peng, Zang Yi, Choo Yeun-Mun, Li Jia, Hu Jin-Feng
Primary Institution: Zhejiang Provincial Key Laboratory of Plant Evolutionary Ecology and Conservation, School of Pharmaceutical Sciences, Taizhou University, Taizhou, China
Hypothesis
Can compounds from Kolkwitzia amabilis inhibit ACC1 and ACL enzymes?
Conclusion
The study identified several compounds from Kolkwitzia amabilis that exhibit moderate to potent inhibitory effects on ACC1 and ACL, suggesting their potential as therapeutic agents.
Supporting Evidence
- 39 structurally diverse compounds were isolated from Kolkwitzia amabilis.
- Compounds 2 and 17 showed moderate inhibitory effects against ACC1.
- Compounds 8, 17, 29, and 31 exhibited potent inhibitory effects on ACL.
Takeaway
Researchers found special plant compounds that can help stop certain enzymes in our body that are linked to health problems like heart disease.
Methodology
Phytochemical investigation and molecular docking studies were conducted to isolate compounds and evaluate their inhibitory effects on ACC1 and ACL.
Limitations
The study primarily focused on in vitro assays, and the effects in vivo remain to be investigated.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website